Imatinib Cessation in Children and Adolescents With Chronic Myeloid Leukemia in Chronic Phase
Imatinib Cessation in Children and Adolescents With Chronic Myeloid Leukemia in Chronic Phase
复制标题
DOI：
10.1002/pbc.24521
复制
发表时间：
2014-02-01
影响因子：
3.2
通讯作者：
Suttorp, Meinolf
中科院分区：
文献类型：
--
作者：
Millot, Frederic;Claviez, Alexander;Suttorp, Meinolf
伊马替尼可以安全地停止在成人慢性粒细胞白血病（CML），其中有一个延长的完全分子反应（CMR）。尚无儿科人群的数据。6例CML患儿自行停用伊马替尼。只有三个人在CMR，
Imatinib can be safely discontinued in adults with chronic myeloid leukemia (CML) where there is a prolonged complete molecular response (CMR). No data are available in the pediatric population. Six children with CML discontinued imatinib by themselves. Only three of them were in CMR but for